胰岛素肽特异性干扰素-γ相关免疫反应在酮症倾向2型糖尿病中的临床意义
本横断面研究纳入75例受试者(急性起病1型糖尿病42例、酮症倾向2型糖尿病33例),用酶联免疫斑点法检测外周血单核细胞对4种胰岛素B链9-23相关肽的干扰素-γ反应。酮症倾向2型糖尿病阳性率为36.4%(12/33),与急性起病1型糖尿病38.1%(16/42)相近,且显著高于既往报告的2型糖尿病8%(2/25;P < .0167)。作者认为胰岛素B链9-23相关肽特异性干扰素-γ相关免疫反应参与部分酮症倾向2型糖尿病的病理生理。
要点
- 酮症倾向2型糖尿病中胰岛素B链9-23相关肽反应性干扰素-γ阳性率为36.4%(12/33),与急性起病1型糖尿病38.1%(16/42)相近。
- 该阳性率显著高于既往报告的2型糖尿病8%(2/25;P < .0167)。
- 在酮症倾向2型糖尿病中,反应性单核细胞频率与年龄及随意血清C肽水平呈负相关,在阳性者中与糖化血红蛋白水平呈正相关。
核心结论
- 作者认为,胰岛素B链9-23相关肽特异性干扰素-γ相关免疫反应参与部分无诱因A-β+酮症倾向2型糖尿病的病理生理。
- 作者认为,免疫反应增强可能反映糖尿病酮症/酮症酸中毒起病时β细胞功能一过性下降和疾病活动度增加,从而在该表型酮症/酮症酸中毒发生中起关键作用。
研究设计与样本
- 横断面研究,纳入75例受试者,其中急性起病1型糖尿病42例、酮症倾向2型糖尿病33例。
- 用酶联免疫斑点法检测外周血单核细胞对4种胰岛素B链9-23相关肽的干扰素-γ分泌反应。
主要发现
- 酮症倾向2型糖尿病中36.4%(12/33)干扰素-γ酶联免疫斑点法结果阳性,急性起病1型糖尿病为38.1%(16/42),两者相近。
- 酮症倾向2型糖尿病阳性率显著高于既往报告的2型糖尿病8%(2/25;P < .0167)。
- 全部酮症倾向2型糖尿病受试者中,B链9-23相关肽特异性干扰素-γ生成单核细胞频率与年龄及随意血清C肽水平呈负相关。
- 干扰素-γ酶联免疫斑点法阳性的酮症倾向2型糖尿病受试者中,该频率与糖化血红蛋白A1c水平呈正相关。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
CONTEXT: Unprovoked A-β+ ketosis-prone type 2 diabetes (KPD) is characterized by the sudden onset of diabetic ketosis/ketoacidosis (DK/DKA) without precipitating factors, negative anti-islet autoantibodies ("A-"), and preservation of β-cell function ("β+") after recovery from DKA. Although this phenotype often appears with acute hyperglycemia and DK/DKA just like acute-onset type 1 diabetes (AT1D), the involvement of anti-islet immune responses remains unknown. OBJECTIVE: We sought to clarify the immunological role of insulin-associated molecules in unprovoked A-β+ KPD. METHODS: In this cross-sectional study, blood samples from 75 participants (42 with AT1D and 33 with KPD) were evaluated for interferon (IFN)-γ-secreting peripheral blood mononuclear cells (PBMCs) reactive to 4 insulin B-chain amino acid 9-23-related peptides (B:9-23rPep) using an enzyme-linked immunospot (ELISpot) assay. RESULTS: Overall, 36.4% (12/33) of KPD participants showed positive IFN-γ ELISpot assay results; the positivity rate in KPD was similar to that in AT1D (38.1%; 16/42) and statistically significantly higher than the previously reported rate in type 2 diabetes (8%; 2/25; P < .0167). Moreover, B:9-23rPep-specific IFN-γ-producing PBMC frequency was negatively correlated with age and ad lib serum C-peptide levels in all KPD participants and positively correlated with glycated hemoglobin A1c level in KPD participants with positive IFN-γ ELISpot results. CONCLUSION: These findings suggest the involvement of B:9-23rPep-specific IFN-γ-related immunoreactivity in the pathophysiology of some unprovoked A-β+ KPD. Moreover, increased immunoreactivity may reflect transiently decreased β-cell function and increased disease activity at the onset of DK/DKA, thereby playing a key role in DK/DKA development in this KPD phenotype.
引用
- Satomura A, Oikawa Y, Haisa A, et al. Clinical Significance of Insulin Peptide-specific Interferon-γ-related Immune Responses in Ketosis-prone Type 2 Diabetes. J Clin Endocrinol Metab. 2022. PMID: 34922394. doi:10.1210/clinem/dgab912
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。